Cargando…

Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524

As previously demonstrated by our research group, the oral multicomponent drug Xraphconn(®) containing GS-441524 was effective at curing otherwise fatal feline infectious peritonitis (FIP) in 18 feline coronavirus (FCoV)-infected cats. The aims of the current study were to investigate, using samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meli, Marina L., Spiri, Andrea M., Zwicklbauer, Katharina, Krentz, Daniela, Felten, Sandra, Bergmann, Michèle, Dorsch, Roswitha, Matiasek, Kaspar, Alberer, Martin, Kolberg, Laura, von Both, Ulrich, Hartmann, Katrin, Hofmann-Lehmann, Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147249/ https://www.ncbi.nlm.nih.gov/pubmed/35632813 http://dx.doi.org/10.3390/v14051069

Ejemplares similares

Clinical Follow-Up and Postmortem Findings in a Cat That Was Cured of Feline Infectious Peritonitis with an Oral Antiviral Drug Containing GS-441524
por: Krentz, Daniela, et al.
Publicado: (2022)

Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524
por: Krentz, Daniela, et al.
Publicado: (2021)

Detection of Feline Coronavirus Variants in Cats without Feline Infectious Peritonitis
por: Jähne, Stéphanie, et al.
Publicado: (2022)

In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus
por: Doki, Tomoyoshi, et al.
Publicado: (2022)

Correlation of Feline Coronavirus Shedding in Feces with Coronavirus Antibody Titer
por: Felten, Sandra, et al.
Publicado: (2020)

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
por: Pedersen, Niels C, et al.
Publicado: (2019)

Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis
por: Jones, Sarah, et al.
Publicado: (2021)

Quantification of GS-441524 concentration in feline plasma using high performance liquid chromatography with fluorescence detection
por: Kimble, Benjamin, et al.
Publicado: (2023)

Patterns of Feline Coronavirus Shedding and Associated Factors in Cats from Breeding Catteries
por: Felten, Sandra, et al.
Publicado: (2023)

Prevalence of Feline Coronavirus Shedding in German Catteries and Associated Risk Factors
por: Klein-Richers, Ute, et al.
Publicado: (2020)

Antiviral treatment using the adenosine nucleoside analogue GS‐441524 in cats with clinically diagnosed neurological feline infectious peritonitis
por: Dickinson, Peter J., et al.
Publicado: (2020)

Thirty‐two cats with effusive or non‐effusive feline infectious peritonitis treated with a combination of remdesivir and GS‐441524
por: Green, Jodie, et al.
Publicado: (2023)

Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study
por: Spiri, Andrea M., et al.
Publicado: (2021)

Feline coronavirus with and without spike gene mutations detected by real-time RT-PCRs in cats with feline infectious peritonitis
por: Emmler, Laura, et al.
Publicado: (2019)

Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524
por: Coggins, Sally J., et al.
Publicado: (2023)

Diagnostic Value of Detecting Feline Coronavirus RNA and Spike Gene Mutations in Cerebrospinal Fluid to Confirm Feline Infectious Peritonitis
por: Felten, Sandra, et al.
Publicado: (2021)

The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
por: Murphy, B.G., et al.
Publicado: (2018)

Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
por: Roy, Meagan, et al.
Publicado: (2022)

Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis
por: Lv, Jinbao, et al.
Publicado: (2022)

Comparative Evaluation of GS-441524, Teriflunomide, Ruxolitinib, Molnupiravir, Ritonavir, and Nirmatrelvir for In Vitro Antiviral Activity against Feline Infectious Peritonitis Virus
por: Barua, Subarna, et al.
Publicado: (2023)

Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge
por: Spiri, Andrea M., et al.
Publicado: (2021)

Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility
por: Spiri, Andrea Monika, et al.
Publicado: (2019)

An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats
por: Cook, Sarah, et al.
Publicado: (2022)

Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study
por: Cosaro, Emma, et al.
Publicado: (2023)

Sensitivity and specificity of a real-time reverse transcriptase polymerase chain reaction detecting feline coronavirus mutations in effusion and serum/plasma of cats to diagnose feline infectious peritonitis
por: Felten, Sandra, et al.
Publicado: (2017)

Pharmacokinetics of Orally Administered GS-441524 in Dogs
por: Yan, Victoria C., et al.
Publicado: (2021)

Stopping Feline Coronavirus Shedding Prevented Feline Infectious Peritonitis
por: Addie, Diane D., et al.
Publicado: (2023)

Cats and kids: how a feline disease may help us unravel COVID-19 associated paediatric hyperinflammatory syndrome
por: Alberer, Martin, et al.
Publicado: (2020)

Candidate Gene Markers Associated with Fecal Shedding of the Feline Enteric Coronavirus (FECV)
por: Bubenikova, Jana, et al.
Publicado: (2020)

Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland
por: Berger, Alice, et al.
Publicado: (2015)

Recurrence rate and long-term course of cats with feline lower urinary tract disease
por: Kaul, Elisabeth, et al.
Publicado: (2019)

Role of Feline Coronavirus as Contributor to Diarrhea in Cats from Breeding Catteries
por: Felten, Sandra, et al.
Publicado: (2022)

Practical and Highly Efficient Synthesis of Remdesivir from GS-441524
por: Hu, Tianwen, et al.
Publicado: (2022)

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
por: Amirian, E. Susan, et al.
Publicado: (2020)

Fecal identification markers impact the feline fecal microbiota
por: Nealon, Nora Jean, et al.
Publicado: (2023)

An efficient synthesis of RNA containing GS-441524: the nucleoside precursor of remdesivir
por: Moorthy, Ramkumar, et al.
Publicado: (2021)

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022)

Exploration of the optimal GS-441524 trough concentration for treating COVID-19
por: Nakano, Yuki, et al.
Publicado: (2023)

Transplacental transfer of Remdesivir and GS‐441524: An ex vivo perfusion study
por: Louchet, Margaux, et al.
Publicado: (2023)

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
por: Yan, Victoria C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5j85mjd97u1d0a9t299s9ui5rg